pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·13h ago·1 min read
save

Long-term brain organoids survive over five years and develop molecular features of human brains

Aug 19, 2026·read at STAT ↗Positive

Researchers at Harvard have kept brain organoids alive for more than five years, observing continued growth and maturation that mirrors human brain development.

The long-term cultures displayed molecular and genetic signatures similar to those found in actual human brains, suggesting they could serve as valuable models for studying early stages of neurological disorders.

The discovery, reported in a STAT+ exclusive article, highlights the potential of organoid technology to improve disease modeling and drug discovery, though further work is needed to translate these findings into clinical applications.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Brain organoids, kept alive more than five years, matured like human brains”

read at STAT ↗
448 words · retrieved 12h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.2
topics
Neurology2Oncology2Vaccine2mRNA Therapeutic2Melanoma

related stories

  • 14h agoKolon TissueGene cuts 37 US staffers after Phase 3 failBioSpace
  • 9h agoTrump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: analystsBioSpace
  • 11h agoSTAT+: Experts scrutinize Huidagene’s disclosures after patient deathSTAT
  • 11h agoSTAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approvalSTAT
  • 12h agoSTAT+: American Cancer Society cancels alcohol industry fundraiserSTAT